ProShares Ultra Nasdaq Biotechnology (BIB) Chart & Stock Price History $50.52 -0.03 (-0.06%) As of 01/17/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends ProShares Ultra Nasdaq Biotechnology Stock Price Performance 5 Day Performance-0.71%1 Month Performance-1.48%3 Month Performance-22.53%6 Month Performance-22.61%Year-To-Date Performance-0.28%1 Year Performance-11.49% Receive BIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address BIB Stock Chart for Saturday, January, 18, 2025 BIB Chart by TradingView ProShares Ultra Nasdaq Biotechnology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$50.55$50.52-0.06%$51.18$50.466,107 shs$60.62 million01/16/2025$50.82$50.55-0.53%$50.70$50.004,633 shs$60.66 million01/15/2025$49.02$50.82+3.67%$51.30$50.057,410 shs$60.98 million01/14/2025$50.88$49.02-3.66%$50.87$48.913,540 shs$58.82 million01/13/2025$50.08$50.88+1.60%$50.89$48.5817,745 shs$61.06 million01/10/2025$52.14$50.08-3.95%$51.11$49.5611,539 shs$60.10 million Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$52.14$52.14$52.33$51.803,584 shs$62.57 million01/08/2025$52.71$52.14-1.08%$52.33$51.803,584 shs$62.57 million01/07/2025$51.81$52.71+1.74%$53.69$52.437,751 shs$63.25 million01/06/2025$51.87$51.81-0.12%$52.69$51.605,432 shs$62.17 million01/03/2025$51.34$51.87+1.03%$52.32$51.693,593 shs$71.58 million01/02/2025$50.66$51.34+1.34%$52.03$50.9010,878 shs$70.85 million01/01/2025$50.66$50.66$50.94$49.965,849 shs$69.91 million12/31/2024$50.23$50.66+0.86%$50.94$49.965,849 shs$69.91 million12/30/2024$51.83$50.23-3.09%$51.01$49.7617,497 shs$69.32 million12/27/2024$52.77$51.83-1.78%$51.97$51.194,994 shs$71.53 million12/26/2024$52.19$52.77+1.11%$52.87$51.418,492 shs$72.82 million12/25/2024$52.19$52.19$52.19$51.518,632 shs$72.02 million12/24/2024$51.90$52.19+0.56%$52.19$51.518,632 shs$72.02 million12/23/2024$51.41$51.90+0.95%$51.98$50.667,549 shs$71.62 million12/20/2024$50.50$51.41+1.80%$52.41$49.496,998 shs$70.95 million12/19/2024$51.28$50.50-1.52%$51.05$49.5012,352 shs$69.69 million12/18/2024$55.78$51.28-8.07%$55.67$50.9616,725 shs$70.77 million12/17/2024$55.40$55.78+0.69%$56.15$55.437,621 shs$76.98 million Related Companies F/m Emerald Life Sciences Innovation ETF Stock Price Chart Invesco Nasdaq Biotechnology ETF Stock Price Chart Horizon Kinetics Medical ETF Stock Price Chart First Trust Nasdaq Pharmaceuticals ETF Stock Price Chart JPMorgan Healthcare Leaders ETF Stock Price Chart ProShares UltraShort Nasdaq Biotechnology Stock Price Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Price Chart Invesco S&P SmallCap Health Care ETF Stock Price Chart VanEck Biotech ETF Stock Price Chart VanEck Pharmaceutical ETF Stock Price Chart Receive BIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIB) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
